<--- Back to Details
| First Page | Document Content | |
|---|---|---|
 Chronic lower respiratory diseases Chronic obstructive pulmonary disease Smoking Phosphodiesterase-4 inhibitor Acute exacerbation of chronic obstructive pulmonary disease Roflumilast Spirometry Tiotropium bromide Pulmonology Respiratory therapy Medicine |
Add to Reading List |
Briefing Book - April 2010 | Läkemedelsnytt Nr 3 – 18 mars 2011 Daxas (roflumilast): Nygammal farmakologisk princip för behandling av KOL En ny selektiv PDE-hämmareDocID: 1dajE - View Document |
| Briefing Book - April 2010DocID: Gi0Z - View Document |
![FDA ERRATA (dated[removed]To FDA Advisory Committee Briefing Documents PULMONARY-ALLERGY DRUGS ADVISORY COMMITTEE MEETING April 7, 2010 NDA[removed]: Daxas (roflumilast 500 mcg tablets)](https://www.pdfsearch.io/img/f192b31f784dd75aeb8b8d920ff1eb9b.jpg "FDA ERRATA (dated[removed]To FDA Advisory Committee Briefing Documents PULMONARY-ALLERGY DRUGS ADVISORY COMMITTEE MEETING April 7, 2010 NDA[removed]: Daxas (roflumilast 500 mcg tablets)") | FDA ERRATA (dated[removed]To FDA Advisory Committee Briefing Documents PULMONARY-ALLERGY DRUGS ADVISORY COMMITTEE MEETING April 7, 2010 NDA[removed]: Daxas (roflumilast 500 mcg tablets)DocID: G9xY - View Document |
![Daxas® (roflumilast) Tablets NDA[removed]Pulmonary-Allergy Drugs Advisory Committee Meeting April 7, 2010](https://www.pdfsearch.io/img/3313e1a21cbff8181ae03e017bdfce83.jpg "Daxas® (roflumilast) Tablets NDA[removed]Pulmonary-Allergy Drugs Advisory Committee Meeting April 7, 2010") | Daxas® (roflumilast) Tablets NDA[removed]Pulmonary-Allergy Drugs Advisory Committee Meeting April 7, 2010DocID: FTyj - View Document |
 | Q&A Slides Presented FDA PADAC Pulmonary-Allergy Drugs Advisory Committee Meeting April 7, 2010DocID: FPD3 - View Document |